scholarly journals Robot-assisted Endoscopic Surgery: Removal of a Huge Tricuspid Valve Myxoma

2021 ◽  
Author(s):  
Lun Wu Hung ◽  
Cheng Ya Lee ◽  
Bor-Chih Cheng
Keyword(s):  
Tricuspid Valve ◽  
Cardiac Tumor ◽  
Tumor Resection ◽  
Cardiac Myxoma ◽  
Minimal Invasive ◽  
Robot Assisted ◽  
En Bloc ◽  
Tumor Excision ◽  
Benign Cardiac Tumor ◽  
Endoscopic Tumor Resection

Cardiac myxoma is the most common benign cardiac tumor. Its tremendous size and fragile character severely bother the surgeons. Several minimal invasive approaches had been applied for radical tumor excision. The wound was forcibly enlarged for en-bloc specimen removal and prevention of debris sputtering. We reported a case of huge tricuspid valve (TV) myxoma managed by robot-assisted endoscopic tumor resection and TV repair. The tumor was downsized with a morcellator and removed through a keyhole wound (1.1 cm in diameter). The patient recovered uneventfully and was discharged after four days.

scholarly journals Recurrent Cardiac Myxoma Treated by Orthotopic Heart Transplantation: A Case Report and Literature Review of Heart Transplantation for Primary Cardiac Tumor

2018 ◽  
Vol 2018 ◽  
pp. 1-7
Author(s):  
Jakrin Kewcharoen ◽  
Klaorat Prasongdee ◽  
Supanee Sinphurmsukskul ◽  
Sarawut Siwamogsatham ◽  
Sarinya Puwanant ◽  
...  
Keyword(s):  
Heart Transplantation ◽  
Heart Transplant ◽  
Cardiac Tumor ◽  
Nyha Class ◽  
Tumor Resection ◽  
Cardiac Myxoma ◽  
Orthotopic Heart Transplantation ◽  
Orthotopic Heart Transplant ◽  
Primary Cardiac Tumor ◽  
Long Term Prognosis

Primary cardiac myxoma is the most common primary cardiac tumor. Tumor resection is the treatment of choice and overall long-term prognosis is good and recurrence is rare. This report presents a case of a young girl who presented with multiple recurrent cardiac myxoma. She underwent 3 sternotomy surgeries of 3 separated episodes of cardiac myxoma resection. On the fourth recurrence, the patient underwent orthotopic heart transplant. The patient tolerated the procedure well and is alive 6 months after the procedure with NYHA class I. We reviewed evidences and summarized reported cases of orthotopic heart transplant operation for primary cardiac tumor in the literature.

scholarly journals Papillary Fibroelastoma of the Right Ventricular Free Wall

2014 ◽  
Vol 2014 ◽  
pp. 1-3
Author(s):  
Tetsuya Niino ◽  
Satoshi Unosawa
Keyword(s):  
Cardiac Tumor ◽  
Main Pulmonary Artery ◽  
Tumor Resection ◽  
Papillary Fibroelastoma ◽  
Free Wall ◽  
Right Ventricular Free Wall ◽  
Postoperative Course ◽  
Resected Tumor ◽  
Benign Cardiac Tumor ◽  
The Right

Papillary fibroelastoma is a rare benign cardiac tumor that usually arises from the valvular endocardium and its development in the cardiac chambers is extremely rare. A 52-year-old woman complained of palpitations and echocardiography revealed a cardiac tumor. Resection was performed via the right ventricle and main pulmonary artery under cardiopulmonary bypass. Histological examination of the resected tumor showed that it was a papillary fibroelastoma. The patient’s postoperative course was unremarkable and no complications have been detected on followup.

scholarly journals Left Atrial Myxoma Presenting As a Stroke – An Unusual Case Scenario

2021 ◽  
Vol 9 (1) ◽  
pp. 84-86
Author(s):  
Pinninti Mounika ◽  
sandhyika B ◽  
Ravinder Reddy Kasturi ◽  
Nikhil Mudgalkar ◽  
Aashish Baviskar
Keyword(s):  
Cardiac Tumor ◽  
Unusual Case ◽  
Cardiac Myxoma ◽  
Atrial Myxoma ◽  
Cardiac Tumors ◽  
Case Scenario ◽  
Left Atrial Myxoma ◽  
Female Predominance ◽  
Benign Cardiac Tumor ◽  
Primary Cardiac Tumors

The most common benign cardiac tumor is cardiac myxoma,accounting for around 50% of all primary cardiac tumors. Cardiac myxoma is an uncommon cause ofcardioembolic stroke.Overall,cardioembolic stroke accounts for approximately 30% of all ischemic stroke of which 0.5% of cardioembolic strokes are attributable to a cardiac myxoma.It has an annual incidence of around 0.5 cases per one million people with female predominance. Early diagnosis is necessary to prevent its devastating complications such as embolic stroke and sudden cardiac death.We present a relatively rare case of an acute stroke as a first and only manifestation of an atrial myxoma

scholarly journals SUDDEN DEATH SYNDROME CAUSED BY CARDIAC TUMOR

2020 ◽  
Vol 54 (1) ◽  
Author(s):  
Dusica Petrovic Rodic
Keyword(s):  
Cardiac Tumor ◽  
Clinical Case ◽  
Staining Method ◽  
Age Groups ◽  
Cardiac Myxoma ◽  
Sudden Death Syndrome ◽  
Cardiac Tumors ◽  
Autopsy Series ◽  
Benign Cardiac Tumor ◽  
Primary Cardiac Tumors

Cardiac tumors are rare (occurring in 0.002-0.3% of autopsies) in all age groups, but they are of clinical relevance due to the affected organ (1). They are classified into primary (benign and malignant) and secondary (metastatic). Myxoma is the most common primary benign cardiac tumor which is usually derived from the multipotent mesenchymal cells of the septum within the left atrium, and due to its localization, it can be considered as "functionally malignant". In autopsy series, it accounts for approximately 50% and in surgical series for up to 80% of all primary cardiac tumors (2). This paper presents a case of cardiac myxoma which is echocardiographically diagnosed in a 34-year-old woman who died suddenly, several days before the scheduled surgery. The diagnosis of the disease was confirmed after the autopsy, by a routine haematoxylin-eosin (H&E) staining method and an additional immunohistochemistry method (IHC). By presenting a rare clinical case, we emphasize the fact that every diagnosed cardiac tumor requires immediate cardiac surgery without delay.   Keywords: cardiac tumors, myxoma, autopsy

Iodine-125 interstitial brachytherapy after tumor excision: an alternative eye-sparing surgery for lacrimal gland carcinoma

2021 ◽  
Author(s):  
Yang-jun Li ◽  
Ping Wang ◽  
Shao-bo Zhang ◽  
Xiao-na Ning ◽  
Chen-jun Guo ◽  
...  
Keyword(s):  
Lacrimal Gland ◽  
Tumor Recurrence ◽  
Tumor Resection ◽  
Interstitial Brachytherapy ◽  
Tumor Excision ◽  
Control Tumor ◽  
Gland Carcinoma ◽  
Iodine 125 ◽  
Good Cosmesis

Abstract Background:To describe the preliminary suppressive effects of iodine 125 brachytherapy for malignant lacrimal gland tumors after excisionMethods:The study recruit 9 patients with lacrimal gland carcinoma from May 2017 to December 2020. All patients underwent eye sparing surgical tumor resection first and then received iodine 125 interstitial brachytherapy to prevent tumor recurrence. We look over whether tumor recurred or metastasized by detecting the visual function and CT/MRI/PET MRI of every patient.Results1 patient was lost visit. The median follow up period was 29 months of other 8 patients (range, 7 43 months). One patient experienced recurrence two years later but was free from local disease after iodine 125 seeds were implanted one more time. The vision of one female patient was lost due to the seeds moving to the optic nerve. In the remaining 6 patients the vision was no changed, and CT/MRI showed no tumor was recurrencedConclusions:Permanent iodine 125 strip implantation in the orbit can be used as an alternative eye sparing surgery for malignant lacrimal gland tumors after tumor excision. It can control tumor recurrence and maintenance of vision and good cosmesis.

Total ulna replacement with a 3D-printed custom-made prosthesis after en bloc tumor resection: A case report

2018 ◽  
Vol 66 (2) ◽  
pp. e27522 ◽  
Author(s):  
Xiang Fang ◽  
Wenli Zhang ◽  
Zeping Yu ◽  
Hongyuan Liu ◽  
Yan Xiong ◽  
...  
Keyword(s):  
Case Report ◽  
Tumor Resection ◽  
En Bloc ◽  
Custom Made ◽  
3D Printed

scholarly journals Mohs Micrographic Surgery Peripheral Margin Control Prior to En Bloc Tumor Resection: A Report of Three Cases

2018 ◽  
Vol 2 (1) ◽  
pp. 49-53
Author(s):  
Daniel Bernstein ◽  
Sara Giddings ◽  
Hooman Khorasani
Keyword(s):  
Plastic Surgery ◽  
Tumor Resection ◽  
Mohs Micrographic Surgery ◽  
Micrographic Surgery ◽  
En Bloc ◽  
Facial Plastic Surgery ◽  
Facial Plastic ◽  
Tumor Extirpation ◽  
The Right ◽  
Margin Control

Background: Mohs micrographic surgery (MMS) is an important part of non-melanoma skin cancer (NMSC) management but may even be useful for tumors that cannot be cleared in an office setting.  There are sparse reports of MMS for peripheral margin control in the dermatology literature but various techniques have been reported.Case 1: 58-year-old male with morpheaform basal cell carcinoma of the left midface treated with MMS peripheral margin control followed by facial plastic surgery central tumor extirpation and defect repair.Case 2: 56-year-old female with recurrent morpheaform BCC of the scalp treated with MMS peripheral margin control followed by facial plastic surgery central tumor extirpation and defect repair.Case 3: 73-year-old male with multiply recurrent SCC of the right lower extremity treated with MMS peripheral margin control followed by above the knee amputation.Conclusions:  MMS peripheral margin control followed by central tumor extirpation and defect reconstruction at a later date in the operating room is an option for deeply invasive, large and aggressive NMSC.  Benefits include decreased time under general anesthesia and superior rates of tumor clearance.  In the interim, the peripheral defect between the central tumor and healthy outer tissue can be sutured closed to decrease patient morbidity.

scholarly journals Retroperitoneal Robot-Assisted Laparoscopic Partial Nephrectomy for Horseshoe Kidney: A Case Report

2021 ◽  
Author(s):  
Dongxu Zhang ◽  
Youyi Lu ◽  
Fengze Sun ◽  
Di Wang ◽  
Xingjun Bao ◽  
...  
Keyword(s):  
Case Report ◽  
Partial Nephrectomy ◽  
Tumor Resection ◽  
Three Dimensional ◽  
Horseshoe Kidney ◽  
Laparoscopic Partial Nephrectomy ◽  
Robot Assisted ◽  
3D Reconstructions ◽  
Case Presentations ◽  
The Right

Abstract Background: Horseshoe kidney (HSK) have always been a challenge for urologists depending on its particular anatomy. We report a case of renal tumor in a patient with HSK, who underwent tumor resection by retroperitoneal robot-assisted laparoscopic partial nephrectomy. Case Presentations: A 47-year-old man presented to our hospital with a solid renal mass. Computed tomography urography (CTU) showed a 4.3 × 4.4 cm mass in the upper pole of the right kidney. Patients received a retroperitoneal robot-assisted laparoscopic partial nephrectomy on basis of three-dimensional (3D) reconstructions.Conclusion: The present case report highlights the feasibility of robot-assisted laparoscopic partial nephrectomy for horseshoe kidney, and the advantages of preoperative 3D reconstructions.

Histologically verified cerebral aneurysm formation secondary to embolism from cardiac myxoma

1995 ◽  
Vol 83 (1) ◽  
pp. 170-173 ◽  
Author(s):  
Kazuhide Furuya ◽  
Tomio Sasaki ◽  
Yuhei Yoshimoto ◽  
Yoshifumi Okada ◽  
Takamitsu Fujimaki ◽  
...  
Keyword(s):  
Tumor Cells ◽  
Cardiac Tumor ◽  
Arterial Wall ◽  
Cardiac Myxoma ◽  
Cerebral Aneurysms ◽  
Surgical Removal ◽  
Arterial Aneurysm ◽  
Content Type ◽  
Aneurysm Formation ◽  
Aneurysm Wall

✓ Multiple aneurysm formation secondary to an embolism from the cardiac myxoma is a well-known phenomenon. The cerebral arterial aneurysm formation process involved remains to be elucidated, although occupation of the arterial wall by tumor cells has been proven histologically. The authors present the case of a patient in whom tumor cells in the aneurysm wall were demonstrated and penetration of viable myxoma cells into the wall was also observed 19 months after surgical removal of the cardiac tumor. Such findings have never before been verified histologically. In light of the histological findings, the authors discuss the therapeutic problems associated with cerebral aneurysms resulting from cardiac myxoma.

Is Robot-assisted Radical Cystectomy the Preferred Minimal Invasive Procedure for Non-advanced Bladder Urothelial Carcinoma(T1-T2N0M0)? A Single Center Retrospective Study.

2020 ◽  
Author(s):  
Ming Xiao ◽  
Zhaohui Zhong ◽  
Jiannan Ren ◽  
Wei Xiong
Keyword(s):  
Urothelial Carcinoma ◽  
Radical Cystectomy ◽  
Operation Time ◽  
Invasive Procedure ◽  
Minimal Invasive ◽  
Postoperative Treatment ◽  
Transfusion Rate ◽  
Robot Assisted ◽  
Bladder Urothelial Carcinoma ◽  
Hospitalization Costs

Abstract Background: To investigate the perioperative efficacy and cost of robot-assisted radical cystectomy(RARC) and laparoscopic RC(LRC) in patients with non-advanced bladder urothelial carcinomaMethods: 156 patients with non-advanced bladder urothelial carcinoma undergoing minimally invasive radical cystectomy in our center between January 2015 and April 2020 were included. Perioperative data and hospitalization expenses were extracted from our database. All analyses were performed using SPSS 23.0 software, and p < 0.05 was considered statistically significant.Results: The proportion of male patients was 86.5%(135/156) and the median age was 65(IQR 59-71) years old. RARC had a lower PSM rate (0 vs 5.3%,P=0.051), longer median operation time(370 vs 305 min,P<0.001) and higher median hospitalization cost(20565.2 vs 15532.4$,P<0.001). There were no significant differences in intraoperative transfusion rate, anesthesia resuscitation in ICU, postoperative hospital stay, 30-d complications and postoperative treatment expenses between the two groups(P=0.815,0.715, 0.817,0.92 and 0.543,respectively.)Conclusion: Short operation time and low hospitalization costs are favorable factors for LRC, but RARC may be the preferred surgical procedure for non-advanced bladder urothelial carcinoma considering the potentially low PSM rate.Trial registration: A complete informed consent was obtained from the patient and their families before the surgery.Informed consent was signed for all patients.This study was approved by the Ethics Review Committee of the Second Xiangya Hospital of Central South University

Sign in / Sign up

Export Citation Format

Share Document